DelMar Pharmaceuticals Analysts Recommendations and Consensus

DMPI -- USA Stock  

USD 0.61  0.0259  4.04%

The current analyst and expert consensus on DelMar Pharmaceuticals is Strong Buy with 0 strong sell and 3 strong buy opinions. The current projected target price consensus is 14.84 with 5 analysts opinions. The most common way DelMar Pharmaceuticals analysists use to provide recommendation to public is financial statements analysis. Many experts also interview DelMar Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on DelMar Pharmaceuticals. We encourage you to use your own analysis of DelMar Pharmaceuticals to validate this buy or sell advice. DelMar Pharmaceuticals buy or sell recommendation module provides average expert sentiment on the projected DelMar Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 3.335. Additionally see Macroaxis Advice on DelMar Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

DelMar Pharmaceuticals Target Price Consensus

Number of Opinions3
Lowered Outlook0
Raized Outlook0
Strong Buy
Macroaxis Recommendation   Exposure   Valuation

DelMar Pharmaceuticals Target Price Projection

Current Price

DelMar Pharmaceuticals Market Quote
Low Price0.615Odds
High Price0.68Odds

0.615

Target Price

Analyst Consensus On Target Price
Low Estimate11.0Odds
High Estimate19.2Odds
Number of Analysts5
Standard Deviation3.335

14.84

DelMar Pharmaceuticals Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Baby Boomer Prospects
Purchased few shares
Traded few hours ago for 79.19
PowerShares QQQ ETF
Purchased few shares
Traded few hours ago for 179.93
Investor Favorites
Purchased few shares
Traded few hours ago for 281.04
Basic Utilities
Sold one share
Traded few hours ago for 42.84
Dividend Beast
Purchased over 90 shares
Traded few hours ago for 45.12
Dividend Beast
Purchased over 90 shares
Traded few hours ago for 61.59
Additionally see Macroaxis Advice on DelMar Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.